Nash Kevin C 4
4 · GENTEX CORP · Filed Feb 21, 2024
Insider Transaction Report
Form 4
GENTEX CORPGNTX
Nash Kevin C
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-20+8,726→ 51,456 total - Exercise/Conversion
Common Stock
2024-02-20$22.94/sh+13,500$309,690→ 57,821 total - Tax Payment
Common Stock
2024-02-20$35.01/sh−4,191$146,732→ 47,265 total - Tax Payment
Common Stock
2024-02-20$35.01/sh−2,944$103,073→ 44,321 total - Sale
Common Stock
2024-02-20$33.04/sh−13,500$446,087→ 44,321 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2024-02-20−13,500→ 13,500 totalExercise: $22.94From: 2019-02-15Exp: 2028-02-15→ Common Stock (13,500 underlying)
Footnotes (4)
- [F1]8,726 shares are performance based shares where the total number of shares granted were based on long term performance incentives.
- [F2]This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price.
- [F3]This transaction was executed in multiple trades at prices ranging from $35.01 to $35.14. The price reported above reflects the weighted average price.
- [F4]These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.